Netrin-4 (Sisene Biotechnology)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNetrin-4 (Sisene Biotechnology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeovascularization, Pathologic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSisene BiotechnologyInserm
Active IndicationsN/A
Inactive IndicationsNeovascularization, Pathologic

Other Information

ATC CodeN/A
Related LinksN/A